Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C3SW
|
||||
| Former ID |
DNCL001692
|
||||
| Drug Name |
Lesinurad
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
Ardea Biosciences
|
||||
| Formula |
C17H14BrN3O2S
|
||||
| InChI |
InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)
|
||||
| InChIKey |
FGQFOYHRJSUHMR-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Solute carrier family 22 member 12 | Target Info | Modulator | [543360] | |
| References | |||||
| Ref 523730 | ClinicalTrials.gov (NCT01493531) Combining Lesinurad With Allopurinol in Inadequate Responders. U.S. National Institutes of Health. | ||||
| Ref 542652 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7673). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.